Thursday, June 30th, 2022 16:47:06

Public Movement and Public Participation are key pillars of India’s COVID management strategy, says Health Minister Mansukh Mandaviya

Updated: March 22, 2022 1:27 pm

Health Minister Mansukh Mandaviya has said that India’s COVID management is a story of leadership, innovation, dedication, partnership, sharing, and leveraging technology. Addressing an event in New Delhi yesterday, Mr Mandaviya said, India presented an exemplary model of COVID management with Centre and States working in unison in a federal democracy. He said, Public Movement and Public Participation are key pillars of India’s COVID management strategy. Mr Mandaviya said, several studies had made ill-informed predictions and assumptions on the impact of the pandemic in India but India’s political leadership took decisive actions at crucial times in a strategic manner by learning from and amalgamating best global practices with its own approach to manage the pandemic.

Appreciating the contribution of healthcare workers in the fight against the Covid-19 pandemic, Dr Mandaviya applauded their motivation and dedication. In this context, the Minister also highlighted the innovative ways in which the Prime Minister encouraged them to contribute their best.

On the government’s efforts in controlling the Covid-19 pandemic, He said, it was a joint effort by a multitude of stakeholders like NGOs, CSOs, industry, development partners. Mr Mandaviya said, administration of more than 181 Crore Vaccine has contributed to the success in management of third surge. He underscored the fact that despite the huge diversity of geographies and population, India demonstrated how a huge vaccination drive can be mounted at scale.

Dr Mandaviya also stated that in keeping with Indian ethos and tradition, the country supplied COVID19 vaccines to the world even before our own vaccine requirement was fully met. He also added that India did not exhibit any arrogant behaviour but shared what it produced. The Minister said, India has provided medicines such as HCQ to many countries and it did not compromise on quality or bargain with the price.

He said, India’s success story presents a takeaway for other countries to emulate, just as it is always open to learning from global best practices.

Comments are closed here.